Surrey Heartlands

Joint Formulary & PAD

Botulinum toxin type A - Facial spasm

You are here : Home > Formulary Search > Botulinum toxin type A - Facial spasm

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
  • RSFT: Opthalmology and Neurology only. Dysport to be supplied to neurology if specifically requested
  • SASH: Xeomin only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Facial spasm
Group Name :
Keywords :
Blepharospasm, hemifacial spasm, myofascial pain
Brand Names Include :
Botox, Xeomin, Dysport
Important Information :

Includes blepharospasm and hemifacial spasm. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Botulinum toxin type A is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Facial spasm.

  • No records returned.

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.